Advances in Plant-Sourced Natural Compounds as Anticancer Agents, 2nd Edition

Dear Colleagues,

After the great success of this Special Issue‘s first edition, we are pleased to inform you that Molecules will launch the second edition of “Advances in Plant-Sourced Natural Compounds as Anticancer Agents”.

https://www.mdpi.com/journal/molecules/special_issues/Q6661R9V2K

Cancer is among the leading causes of death worldwide. Generally, cancer rates are highest in countries with populations that have the highest life expectancy, education level, and standard of living. The principal purpose of current cancer therapy is to perturb or kill the malignant cells from early-stage neoplasms or those remaining after surgery without affecting the normal cytophysiological processes, and to trigger immune defense against residual tumor cells. Natural products are rich sources of bioactive molecules for new anticancer drugs. Phytochemicals show great potential in improving the clinical condition of cancer patients, as demonstrated by numerous preclinical and clinical studies. Plant-sourced natural compounds have diverse biological activities, including antioxidant and anticancer effects. Recently, many emerging studies have revealed the uses of plant-sourced natural compounds and individual anticancer drugs that could be promising combinations in hampering multiple signaling pathways involved in cancer development and progression. In addition to enhancing the therapeutic efficacy, this has also been proven to reduce the dosage of chemotherapeutic drugs, overcoming multiple drug resistance and minimizing treatment side effects. This Special Issue focuses on recent research regarding plant-sourced natural compounds with anticancer activity through various mechanisms and novel pharmaceutical formulations with potential applications in prophylaxis and the treatment of neoplasia.

Dr. Violeta Popovici
Dr. Emma Adriana Ozon
Prof. Dr. Cerasela Elena Gîrd
Prof. Dr. ‪Dumitru Lupuliasa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.